Questex Fierce Pharma And MCH Group Launch "Fierce Pharma Week Europe" in Basel
Eva Mai
Questex, owner of Fierce Pharma and Fierce Pharma Week, is bringing its flagship pharma event to Europe for the first time. In partnership with MCH Group, the inaugural Fierce Pharma Week Europe will take place June 28–30, 2027, in Basel, gathering cross-functional pharma leaders from marketing, medical affairs, market access, and communications.
The event responds to a European pharma industry in flux, shaped by shifting U.S. drug-pricing policy, the EU's new Life Sciences Strategy, and the rapid rise of Chinese biopharma — trends that are pushing global pharma companies to rethink how they approach the European market. "Europe is entering a new era of pharmaceutical competition, and there has never been a better time to bring the Fierce Pharma Week franchise to the region," said Rhiannon James, President, Life Sciences, Health & Wellness at Questex.
Basel was chosen for its density of life sciences activity: more than 800 companies, over 1,000 research groups, and around 33,000 industry professionals are based in the region.
"Questex's choice of Basel as the home of its European edition underscores the strength of the local life sciences hub. This partnership strengthens Basel's position as a destination for international life sciences events and reflects our ambition to build a portfolio of globally relevant life sciences platforms."
Program details, speakers, and sponsorship opportunities will be announced in the coming months.
